Abstract
BackgroundThe use of TNF-alpha inhibitors is associated with an increased risk of tuberculosis (TB) and all guidelines recommend discontinuation of TNF-alpha inhibitors if active TB develops. However discontinuation of treatment...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
